Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 336.00
+9.00 (2.75%)
Feb 13, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 30.29 billion as of February 13, 2026.
Market Cap
30.29B
Enterprise Value
26.30B
Revenue
2.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
336.00
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 30.29B, an increase of 72.92%. That is a compound annual growth rate of 93.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 29.48B | 10.54% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 39.10B |
| Shanghai Junshi Biosciences | 35.48B |
| Biocytogen Pharmaceuticals (Beijing) | 35.09B |
| TransThera Sciences (Nanjing) | 27.89B |
| Genscript Biotech | 27.05B |
| PegBio | 26.11B |
| InnoCare Pharma | 25.40B |
| Ascletis Pharma | 17.87B |